USE OF DALBAVANCIN IN THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS IN THE SPANISH HOSPITAL SETTING: A COMPARATIVE COST ANALYSIS

被引：0
|
作者：
Hernandez, I [1 ]
Carcedo, D. [1 ]
Sabaniego, J. [2 ]
Rossello, I [2 ]
Jimenez, A. [3 ]
机构：
[1] Hygeia, Madrid, Spain
[2] Angelini Pharma Espana SLU, Barcelona, Spain
[3] Hosp Univ Virgen de las Nieves, Granada, Spain
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE669
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [21] Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
    Adam G. Pizzuti
    E. Yancy Murray
    Jamie L. Wagner
    Derek A. Gaul
    Christopher M. Bland
    Bruce M. Jones
    [J]. Infectious Diseases and Therapy, 2020, 9 : 1043 - 1053
  • [22] Single-Dose Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
    Karly P. Garnock-Jones
    [J]. Drugs, 2017, 77 : 75 - 83
  • [23] Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin
    Volpicelli, Lorenzo
    Venditti, Mario
    Oliva, Alessandra
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (04) : 329 - 341
  • [24] Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
    McCarthy, Matthew W.
    Keyloun, Katelyn R.
    Gillard, Patrick
    Choi, Justin J.
    Pickell, Nicholas
    Copp, Ronald
    Walsh, Thomas J.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2020, 9 (01) : 53 - 67
  • [25] Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
    Matthew W. McCarthy
    Katelyn R. Keyloun
    Patrick Gillard
    Justin J. Choi
    Nicholas Pickell
    Ronald Copp
    Thomas J. Walsh
    [J]. Infectious Diseases and Therapy, 2020, 9 : 53 - 67
  • [26] Nosocomial Infections With Methicillin-Resistant Staphylococcus Aureus (SARM) Potentially Avoided With the Use of Dalbavancin During Hospital Treatment of Acute Bacterial Skin and Skin Structure Infections in Spain
    Hernandez, M.
    Carcedo, D.
    Rossello, J.
    Sabaniego, J.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S200 - S200
  • [27] Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: a systematic review and meta-analysis
    Monteagudo-Martinez, Nuria
    Solis-Garcia del Pozo, Julian
    Nava, Eduardo
    Ikuta, Ichiro
    Galindo, Maria
    Jordan, Joaquin
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (11) : 1477 - 1489
  • [28] Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings
    Lovecchio, Frank
    Mccarthy, Matthew W.
    Ye, Xiaolan
    Henry, Alasdair D.
    Doan, Quan, V
    Lock, John L.
    Riccobene, Todd
    Lyles, Rosie D.
    Talan, David A.
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2024, 67 (02): : e217 - e229
  • [29] Role or oritavancin and dalbavancin in acute bacterial skin and skin structure infections and other potential indications
    Bassetti, Matteo
    Labate, Laura
    Vena, Antonio
    Giacobbe, Daniele R.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2021, 34 (02) : 96 - 108
  • [30] A thorough QT study with dalbavancin: A novel lipoglycopeptide antibiotic for the treatment of acute bacterial skin and skin-structure infections
    Dunne, Michael W.
    Zhou, Meijian
    Darpo, Borje
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (04) : 393 - 398
12345